new glp-1 drug retatrutide Promises Big Weight Loss, but Safety Remains a Question Retatrutide Where to Get: Can

Discussion In our nationwide cohort study, use of GLP-1RAs was inversely associated with prostate cancer risk compared with use of basal insulin in the per-protocol analysis

CJEM 2018;20:S61-3

Similarly, Eric Polley, PhD, a UChicago data science and public health expert, recently led a study published in Nature Cardiovascular Research that used statistical modeling to emulate a clinical trial comparing the effects of four different classes of diabetes medication in patients with moderate cardiovascular risk

As a GLP-1 receptor agonist, it is primarily prescribed to lower blood glucose levels in adults who have type 2 diabetes when traditional oral medications or lifestyle adjustments alone are insufficient

Patients should seek immediate medical attention for severe abdominal pain

GLP-1 receptor agonists are injected subcutaneously into three primary anatomical sites: the abdomen, lateral thigh, and upper arm